Seasonal Influenza Therapeutics in Asia-Pacific Markets Key Trends, Size, Growth, Shares And Forecast Research Report 2022

The seasonal influenza Asia-Pacific market will be valued at $1.71 billion in 2022, growing from $1.24 billion in 2015 at a CAGR of 4.7%. Trivalent and quadrivalent vaccines dominate the seasonal influenza market, but unmet needs exist in terms of safety and efficacy. To Get Sample Copy of Report visit @ http://www.researchmoz.us/enquiry.php?type=S&repid=950608
http://www.researchmoz.us/seasonal-influenza-therapeutics-in-asiapacific-markets-to-2022-growth-driven-by-rising-elderly-population-growing-awareness-and-launch-of-quadrivalent-therapies-report.html